EUVIMEDEUVIMED entdecken
Crossref

Protective effect of cistanoside A on dopaminergic neurons in Parkinson's disease via mitophagy

Chengcheng Xu, Yao Wu, Lili Tang, Yan Liang, Yang Zhao iD

Biotechnology and Applied Biochemistry · 2023-02 · 70 (1) · 268-280

DOI: 10.1002/bab.2350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, online erschienen am 05.05.2022. Verfasst von Chengcheng Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Parkinson Disease, MPTP Poisoning, Neuroprotective Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Jiangsu Province TCM Leading Talents Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the main pathological features of Parkinson's disease (PD) is the loss of dopaminergic neurons in the substantia nigra compacta (SNc). Cistanoside A (CA) has a strong neuroprotective effect in PD, but the exact mechanism is unclear. In the present study, the MPTP‐stimulated mouse model of PD and MPP + ‐treated PD model in the MES23.5 neuronal cell model of PD were used to investigate the neuroprotective effects of CA on PD and its potential mechanism. The in vivo experiment results indicated that CA improved the motor function in mice and increased the number of tyrosine hydroxylase positive cells in SNc. In vitro experiments showed that CA reduced the MPP + ‐induced decrease in neurons and mitochondrial membrane potential and promoted the activation of autophagosomes. Furthermore, we found that CA promoted the recruitment of PINK1 and Parkin aggregation to impair mitochondrial membranes and inhibited mitochondrial damage via LC3‐ and p62‐mediated autophagy. In conclusion, CA protects against MPTP‐induced neurotoxicity in vivo and MPP + ‐induced neurotoxicity in vitro, possibly by promoting the PINK1/Parkin/p62 pathway to accelerate the degradation of damaged mitochondria thereby reducing oxidative stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMPTP PoisoningNeuroprotective AgentsMiceAnimalsDopaminergic NeuronsMitophagyUbiquitin-Protein LigasesProtein KinasesMice, Inbred C57BLCatecholsGlycosides

Stichwörter der Autor:innen

MPTP/MPP+PINK1/ParkinParkinson's diseasecistanoside Adopaminergic neurons

Substanzen

Neuroprotective AgentsUbiquitin-Protein LigasesProtein Kinasescistanoside ACatecholsGlycosides

Autor:innen und Institutionen

  • Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Department of Neurology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Department of Neurology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.

ORCID-Profile: Yang Zhao

Förderung

  • Jiangsu Province TCM Leading Talents Project

Zitieren

APA

Xu, C., Wu, Y., Tang, L., Liang, Y., & Zhao, Y. (2023). Protective effect of cistanoside A on dopaminergic neurons in Parkinson's disease via mitophagy. Biotechnology and Applied Biochemistry, 70(1), 268-280. https://doi.org/10.1002/bab.2350

Vancouver

Xu C, Wu Y, Tang L, Liang Y, Zhao Y. Protective effect of cistanoside A on dopaminergic neurons in Parkinson's disease via mitophagy. Biotechnology and Applied Biochemistry. 2023;70(1):268-280. doi:10.1002/bab.2350

BibTeX
@article{Xu2023,
  author = {Xu, Chengcheng and Wu, Yao and Tang, Lili and Liang, Yan and Zhao, Yang},
  title = {Protective effect of cistanoside A on dopaminergic neurons in Parkinson's disease via mitophagy},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2023},
  volume = {70},
  number = {1},
  pages = {268--280},
  doi = {10.1002/bab.2350}
}
Kostenlos starten →